ArticleThe Journal of urology2020

Re: STAG2 is a Biomarker for Prediction of Recurrence and Progression in Papillary Non-Muscle-Invasive Bladder Cancer.

Sam S ChangPubMed ↗Publisher ↗

No numbers read from the abstract.